MAPS Public Benefit Corp. filed an application on Tuesday with the U.S. Food and Drug Administration to approve the psychedelic drug MDMA — also known as Ecstasy — in combination with therapy to treat post-traumatic stress disorder, in what would be the first treatment of its kind.
Democracy Dies in Darkness
FDA to review MDMA-assisted therapy, a milestone for psychedelics
and
December 12, 2023 at 3:50 p.m. EST